You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches
Gastroenterology

National Eosinophil Awareness Week 2024 | May 19-25

In recognition of National Eosinophil Awareness Week, ADVENT is providing medical education resources to increase awareness of eosinophilic esophagitis (EoE).

Ikuo Hirano
Margaret (Peggy) Marcon
Nirmala Gonsalves
MD
Ikuo Hirano +2 more
Past event
19May2024

Learning objectives

  • Identify patients’ adaptive behaviors to unmask disease burden and better understand the impact of EoE beyond symptoms
  • Learn about different tools to assess the impact of EoE and the importance of multidimensional assessment when monitoring EoE

Description

In recognition of National Eosinophil Awareness Week, ADVENT will be working to increase awareness of eosinophilic esophagitis (EoE) by providing medical education resources. Discover more about the latest advances in the science of type 2 inflammation and explore how the latest scientific advances may help clinicians improve the quality of life of their patients with EoE. 

Tags
multiple disease dimensionsquality of lifesymptomseosinophils
MAT-GLB-2401309 - 1.0 - 04/2024; MAT-US-2403359 v1.0 - P Exp. Date: 04/05/2026

Speakers

Gastroenterology
MD

Ikuo Hirano

Professor of Medicine | Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

Gastroenterology
MD

Margaret (Peggy) Marcon

Professor of Medicine | Hospital for Sick Children (SickKids), Toronto, Ontario, Canada

Gastroenterology
MD

Nirmala Gonsalves

Professor of Medicine in the Division of Gastroenterology & Hepatology | Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

Related resources

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?
Gastroenterology
audio

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?

Assessing EoE: Assessing Symptoms in Patients With EoE
Gastroenterology
expert video

Assessing EoE: Assessing Symptoms in Patients With EoE

EoE Burden and Pathophysiology of Type 2 Inflammation
Gastroenterology
videoanimation

EoE Burden and Pathophysiology of Type 2 Inflammation

Adaptive Behaviors in EoE Infographic
Gastroenterology
Infographic

Adaptive Behaviors in EoE Infographic

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi | Regeneron Logo

© 2024 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ArgentinaChange country/region